EUVIMEDEUVIMED entdecken
Crossref

Robotic gastrectomy was reliable option for overweight patients with gastric cancer: a propensity score matching study

Ling-Hua Wei, Hua-Long Zheng, Zhen Xue, Bin-Bin Xu, Hong-Hong Zheng, Li-Li Shen, Zhi-Wei Zheng, Jian-Wei Xie, Chao-Hui Zheng, Chang-Ming Huang, Qi-Yue Chen, Ping Li iD

Surgical Endoscopy · 2024

DOI: 10.1007/s00464-024-10845-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Ling-Hua Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, China. Hauptthemen laut MEDLINE: Gastrectomy, Propensity Score, Robotic Surgical Procedures, Stomach Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The role of minimally invasive surgery using robotics versus laparoscopy in resectable gastric cancer patients with a high body mass index (BMI) remains controversial. METHODS: A total of 482 gastric adenocarcinoma patients with BMI ≥ 25 kg/m2 who underwent minimally invasive radical gastrectomy between August 2016 and December 2019 were retrospectively analyzed, including 109 cases in the robotic gastrectomy (RG) group and 321 cases in the laparoscopic gastrectomy (LG) group. Propensity score matching (PSM) with a 1:1 ratio was performed, and the perioperative outcomes, lymph node dissection, and 3-year overall survival (OS) and disease-free survival (DFS) rates were compared. RESULTS: After PSM, 109 patients were included in each of the RG and LG groups, with balanced baseline characteristics. Compared with the LG group, the RG group had similar intraoperative estimated blood loss [median (IQR) 30 (20-50) vs. 35 (30-59) mL, median difference (95%CI) - 5 (- 10 to 0)], postoperative complications [13.8% vs. 18.3%, OR (95%CI) 0.71 (0.342 to 1.473)], postoperative recovery, total harvested lymph nodes [(34.25 ± 13.43 vs. 35.44 ± 14.12, mean difference (95%CI) - 1.19 (- 4.871 to 2.485)] and textbook outcomes [(81.7% vs. 76.1%, OR (95%CI) 1.39 (0.724 to 2.684)]. Among pathological stage II-III patients receiving chemotherapy, the initiation of adjuvant chemotherapy in the RG group was similar to that in the LG group [median (IQR): 28 (25.5-32.5) vs. 32 (27-38.5) days, median difference (95%CI) - 3 (- 6 to 0)]. The 3-year OS (RG vs. LG: 80.7% vs. 81.7%, HR = 1.048, 95%CI 0.591 to 1.857) and DFS (78% vs. 76.1%, HR = 0.996, 95%CI 0.584 to 1.698) were comparable between the two groups. CONCLUSION: RG conferred comparable lymph node dissection, postoperative recovery, and oncologic outcomes in a selected cohort of patients with BMI ≥ 25 kg/m2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastrectomyPropensity ScoreRobotic Surgical ProceduresStomach NeoplasmsLaparoscopyHumansMaleFemaleMiddle AgedRetrospective StudiesAgedOverweightAdenocarcinomaLymph Node ExcisionPostoperative ComplicationsDisease-Free Survival

Stichwörter der Autor:innen

Gastric cancerLaparoscopic gastrectomyMinimally invasive surgeryOverweightRobotic gastrectomy

Autor:innen und Institutionen

  • Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, China.
  • Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350001, China.
  • Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, 350001, China.
  • Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, 350001, China. hcmlr2002@163.com.
  • Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350001, China. hcmlr2002@163.com.
  • Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, 350001, China. hcmlr2002@163.com.

ORCID-Profile: Ping Li

Zitieren

APA

Wei, L. H., Zheng, H. L., Xue, Z., Xu, B. B., Zheng, H. H., Shen, L. L., Zheng, Z. W., Xie, J. W., Zheng, C. H., Huang, C. M., Chen, Q. Y., & Li, P. (2024). Robotic gastrectomy was reliable option for overweight patients with gastric cancer: a propensity score matching study. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-10845-4

Vancouver

Wei LH, Zheng HL, Xue Z, Xu BB, Zheng HH, Shen LL, et al. Robotic gastrectomy was reliable option for overweight patients with gastric cancer: a propensity score matching study. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-10845-4

BibTeX
@article{Wei2024,
  author = {Wei, Ling-Hua and Zheng, Hua-Long and Xue, Zhen and Xu, Bin-Bin and Zheng, Hong-Hong and Shen, Li-Li and Zheng, Zhi-Wei and Xie, Jian-Wei and Zheng, Chao-Hui and Huang, Chang-Ming and Chen, Qi-Yue and Li, Ping},
  title = {Robotic gastrectomy was reliable option for overweight patients with gastric cancer: a propensity score matching study},
  journal = {Surgical Endoscopy},
  year = {2024},
  doi = {10.1007/s00464-024-10845-4}
}
Kostenlos starten →